![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Amir Fathi, MD
Specialities: Acute Myeloid Leukemia, Myelodysplastic Syndromes
Spoken languages: English
Clinical Expertise
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
About
Dr. Fathi focuses his research on the development and clinical translation of novel therapies for acute leukemias. He currently leads multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies. He has a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.
Location
Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA
Get the latest thought leadership on your Myelodysplastic Syndromes delivered straight
By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:
Follow Us
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811